Alderley Park United Kingdom

Exhibiting at booth 83/84

Alderley Park offers 1m sq ft of state-of-the-art chemistry, biology and pathology labs, dedicated incubator facilities and a range of shared scientific services.

Mrs Elaine Wilson
Head of Scientific Sales 

CIMYM BioSciences Ltd United Kingdom

CIMYM BioSciences was established to develop oncology and immunological therapeutics.  At CIMYM we believe passionately that drug development can only be successful if it is patient centred; ‘Begin with the patient in mind…’
As a healthcare company we recognise an exceptional idea to fill a medical need, build a network and then establish a clinical utility that will improve patient care.  CIMYM uses its expertise to manage value-enhancing activities in the development process of pharmaceuticals and diagnostics. It takes a patient-centred approach to co-develop innovative products and in turn licenses the rights for manufacture and marketing to other pharmaceutical companies for license fees and royalty payments.
CIMYM BioSciences attendance at Bio-Europe will provide a springboard to establish business contacts within the US, European and Asian Biotech markets.
Ms Yvonne Joseph
Ms Yvonne Joseph
LinkedIn logo Managing Director 

Clinical Network Services (UK) United Kingdom

Clinical Network Services (CNS) is an integrated service group focused on product development and has offices in Australia, New Zealand, the UK and the USA.  CNS creates value for small-medium sized biotechnology companies by progressing early stage products into phase 1 & 2 clinical trials or the marketplace sooner.  CNS offers a unique service where it integrates BioDesk, an intelligent global product development and regulatory affairs consultancy, with our committed, highly experienced Australian/New Zealand clinical services and biometrics team.  CNS’ regional clinical advantage is driven by the extremely pragmatic regulatory environment in Australia and New Zealand that makes it possible for clients to enter the clinic quickly, without prior regulatory approval. 

CNS offers a uniquely differentiated, customer-orientated suite of services to clients which enables CNS to guide products efficiently through critical post-discovery development and into initial human trials. Throughout, CNS takes a global development/ regulatory strategic approach to ensure that value is added at every stage of the product development life cycle.

Mr Paul Cronin
Director 
Mr Russell Neal
Managing Director 

IDACO Consulting United Kingdom

IDACO Consulting Limited is a solution-oriented consultancy with a specific focus on supporting companies in the Pharmaceutical, Biotechnology, Medical Device, Life Science and Healthcare sectors.
 
Using our pre-clinical and clinical expertise, along with an extensive network of academic, outsourcing and commercial contacts, we support the development and commercialisation of bio-pharmaceutical products and medical devices.

Our service offering includes:

Pharmaceutical, Medical Device & Healthcare Consulting

    ·   Pre-Clinical & Clinical Development
    ·   Strategy Development & Implementation
    ·   Medical Affairs,  Medical Education & Market Access Support
    ·   Regulatory & Post-Approval Services

Technical Due Diligence, Gap Analysis & Remediation

Business Development

    ·   ‚ÄčSourcing Collaborative & Licensing Opportunities
    ·   Providing Out-Licensing Support
    ·   Bridging Academia to Industry and Industry to Academia

‚ÄčIDACO Consulting also supports clients who are looking to identify new opportunities for collaboration and licensing through its extensive and purpose-built network of technology transfer and business developments contacts. We have access to over 400 universities and research institutions across 26 European countries.

Mr Ian Cox
Director